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We retrospectively analyzed early postoperative complications in 293 consecutive patients with bladder
cancer who underwent radical cystectomy with urinary diversion from 1990 to 2007 at the Department of
Urology of the Sapporo Medical University School of Medicine. The Common Terminology Criteria for
Adverse Events (ver 3.0) was used to evaluate complications that occurred within 30 days after surgery, and
grade 3 and higher grades according to the criteria were defined as complications in this study. The
guidelines of the Centers for Disease Control and Prevention were used for the classification of surgical site
infection. Early postoperative complications were found in 158 cases (54%). Acute pyelonephritis (APN),
which was related to the removal of the ureteral catheter, was the most frequent complication, found in 96
(33%), followed by surgical site infection in 39 (13%), and ileus in 33 (11%). When transient APN was
excluded, the rate for complications was 30%. Possible life-threatening complications were experienced in
15 patients (5%) including 2 (0.7%) who eventually died of the complications. The preoperative grade 3
score of the American Society of Anesthesiologists (ASA score) was significantly related to development of
early postoperative complications in univariate analysis. In multivariate analysis, a grade 3 ASA score and
the estimated blood loss were independent factors to predict development of early complications.
Postoperative nasogastric tubing was not related to ileus after surgery, suggesting that postoperative
indwelling of the tube is not routinely needed. Although about half of the patients experienced early
postoperative complications, they were usually transient and manageable. Thus, careful evaluation of the
preoperative ASA score and a reduction in the amount of bleeding during surgery may lower the
development of early postoperative complications.
(Hinyokika Kiyo 56 : 605-611, 2010)





















































新膀胱吻合には Le Duc-Camey 法16)を原則行った．た
だし 5例にのみ Nesbit 法を行った17)．尿路変向後の
尿管には術中 6 Fr 尿管カテーテルを留置した．新膀





貯血式自己血を原則 800∼1,200 ml 採取した．2003年
4月以降は，ヘモグロビン値 12 g/dl 未満の症例や，
虚血性心疾患の既往のある症例を除いては，術直前に








られていた．1996年以降は第 1，第 2 世代セフェム
系，ペニシリン系抗菌薬を用いた．術日は手術開始30
分前に 1回目を投与し，以後 3時間ごと手術終了まで


















剤も術後 7 日目まで貼付し，手術部位感染 (surgical
site infection : SSI) の徴候がなければ術後 7日目に抜糸
とした．2004年からは正中創の筋膜縫合の後に皮下を



















mon Terminology Criteria for Adverse Events ver 3.0―日
本語訳 JCOG 版― (CTCAE ver 3.0)22)で grade 3 以上
のものと定義した．SSI に関しては the Guideline of the
Centers for Disease Control and Prevention (CDC Guide-
line) に準じて分類し，deep もしくは organ/space を
合併症と定義した23)．
統計学的解析には Stat View-J 5.0 (SAS Institute，
Cary，NC) を使用した．合併症の予測因子の解析に
は，単変量解析は Mann-Whitney’s U test，Chi-square
test，Fisher’s exact probability test (ASA スコア，硬膜外
麻酔）を，多変量解析はロジスティック回帰を用いて





95％の症例が ASA スコア 2以下であり， 4以上の
















ml であった (Table 2）．同種血輸血は73％の症例で施
行しており，中央値は 4単位であった．自己血採取は
122例（42％）で施行し，中央値は 800 ml であった．
手術時間と出血量に影響を与えると思われる尿道摘除






Median age, year 66 [35-94]
Gender (male/female) 238/55 (81％/19％)
Median BMI, kg/m2 22.7 [13.7-31.2]
Smoking history 201 ( 69％)
ASA score
1 93 ( 32％)
2 186 ( 63％)
3 14 ( 5％)
Clinical stage
≦T1 30 ( 10％)
T2 105 ( 36％)
T3 63 ( 22％)
T4 65 ( 22％)
N＋M− 24 ( 8％)
M＋ 6 ( 2％)
Prior illness/comorbidity 149 ( 51％)
Hypertension 90 ( 31％)
Diabetes mellitus 42 ( 14％)
Ischemic heart disease 18 ( 6％)
COPD1)/bronchial asthma 19 ( 6％)
Prior abdominal surgery 120 ( 41％)
Prior pelvic radiation 2 (0.6％)
Neoadjuvant chemotherapy 73 ( 25％)
1) : chronic obstructive pulmonary disease
Table 3. Median operative time and blood loss classified by the types of urinary diversion
Type of urinary diversion(number of patients) Median operative time (minutes) [range] Median blood loss (ml) [range]
Ileal conduit (188) 450 [265-733] 1,735 [ 345-6,300]
With urethrectomy (104) 560 [265-614] 1,855 [ 630-6,300]
Ileal neobladder (68) 485 [320-672] 2,223 [ 700-6,500]
Continent reservoir (23) 551 [456-725] 3,030 [1,100-5,820]
With urethrectomy (15) 534 [478-725] 2,500 [1,100-5,820]
Ureterostomy (7) 315 [230-415] 1,400 [ 920-3,000]
With urethrectomy (3) 355 [315-415] 1,220 [ 950-3,000]
Others (7) 320 [195-455] 2,900 [1,380-3,600]
Table 2. Surgical parameters
Number of
patients (％) [range]
Median operative time, minutes 465 [195- 733]
Median anesthetic time, minutes 520 [238- 960]
Median blood loss, ml 1,910 [345-6,500]
Intraoperative transfusion 215 (73％)
Median intraoperative transfusion,
unit 4 [0-28]




Extended 12 ( 4％)
None 4 ( 1％)
Postoperative nasogastric tubing 192 (65％)
Median epidural tubing, day 3 [0-10]
Urinary diversion
Ileal conduit 188 (64％)
Ileal neobladder 68 (23％)
Continent reservoir 23 ( 8％)
Ureterostomy 7 ( 2％)
Others 7 ( 2％)
Median hospitalization period, days 37 [14-216]











性腎盂腎炎 (acute pyelonephritis : APN) であり，多く
は尿管カテーテルの抜去に続発していた．発熱は一過
性で重症感染症を引き起こした例はなかった．続いて













Table 5. The risk factors for the early postoperative complications
Variable Univariate Multivariate HR (95％ CI)
Patient characteristics
Operation period (1990-2000 vs 2001-2007) 0.1959 0.9104
Age (continuous figure) 0.6750 0.6855
Gender (male vs female) 0.2279 0.5573
ASA score (≦2 vs 3≦) 0.0047 0.0438 3.550 (1.035-12.173)
Smoking history (yes vs no) 0.1037 0.1971
Prior illness/comorbidity (≦1 vs 2≦) 0.9663 0.7062
BMI (continuous figure) 0.5288 0.3710
Prior abdominal surgery (yes vs no) 0.5101 0.3566
Neoadjuvant chemotherapy (yes vs no) 0.7302 0.4641
Clinical stage (≦T2 vs T3≦) 0.4435 0.3004
Pathological stage (≦T2 vs T3≦) 0.1675
Surgical parameters
Operation time (continuous figure) 0.8226 0.1495
Anesthetic time (continuous figure) 0.7412
Estimated blood loss (continuous figure) 0.0670 0.0107 1.182 (1.040- 1.345)
Lymph node dissection (pelvic vs others) 0.0536 0.2134
Urethrectomy in male patients (yes vs no) 0.7827
Post operative nasogastric tubing (yes vs no) 0.3923 0.4819
Epidural tubing (yes vs no) ＞0.999
Type of urinary diversion (IC/IN/CR/Ur and Others)* 0.0657 0.8909
* IC : ileal conduit, IN : ileal neobladder, CR : continent reservoir, Ur : ureterostomy.





Ischemic heart disease 1 (0.3％)
Infectious endocarditis (IE) 13,4) (0.3％)





Entero-anastomotic leakage 23,5) (0.7％)
Rectal injury 2 (0.7％)
Infectious
Acute pyelonephritis 96 (33％)




Uretero-intestinal stricture 13 (4.4％)
1) Grade 3 or higher grade of adverse events according to the
Common Terminology Criteria for Adverse Events ver 3.0 were
regarded as complications. 2) The guidelines of the Centers for
Disease Control and Prevention, were used for the classification
of SSI. 3) Septic shock, which was defined as sepsis-induced
hypotension that required inotropic and vasopressor therapy,
occurred in 2 with ileus, 2 with entero-anastomotic leakage, 2
with SSI, 1 with IE and 1 with pneumonia. 4) One patient died
of infectious endocarditis and the other, ileus. 5) One patient in
entero-anastomotic leakage developed acute respiratory distress
syndrome.
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独立した予測因子となった．なお ASA スコア 3以上
















































Table 6. Early postoperative complications in patients with higher ASA score or intraoperative blood loss greater than
3,000 or 4,000 ml
Complications ≧ASA 3 (14 patients) ＞3,000 ml blood loss (63 patients) ＞4,000 ml blood loss (26 patients)
Cardiovascular
Ischemic heart disease 0 1 (1.6％) 1 (3.8％)
Respiratory
Pneumonia 0 2 ( 3％) 0
Gastrointestinal
Ileus 2 (14％) 0 3 (12％)
Infectious
Acute pyelonephritis 10 (71％) 37 (59％) 17 (65％)
SSI 5 (36％) 11 (17％) 9 (35％)
Genitourinary
Uretero-intestinal stricture 2 (14％) 2 ( 3％) 0
























今回は報告すべき合併症を ｢CTCAE ver 3.0 における
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